218 related articles for article (PubMed ID: 30684519)
1. A key anti-viral protein, RSAD2/VIPERIN, restricts the release of measles virus from infected cells.
Kurokawa C; Iankov ID; Galanis E
Virus Res; 2019 Apr; 263():145-150. PubMed ID: 30684519
[TBL] [Abstract][Full Text] [Related]
2. Mitophagy enhances oncolytic measles virus replication by mitigating DDX58/RIG-I-like receptor signaling.
Xia M; Gonzalez P; Li C; Meng G; Jiang A; Wang H; Gao Q; Debatin KM; Beltinger C; Wei J
J Virol; 2014 May; 88(9):5152-64. PubMed ID: 24574393
[TBL] [Abstract][Full Text] [Related]
3. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
4. Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production.
Naniche D; Yeh A; Eto D; Manchester M; Friedman RM; Oldstone MB
J Virol; 2000 Aug; 74(16):7478-84. PubMed ID: 10906201
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.
Achard C; Boisgerault N; Delaunay T; Roulois D; Nedellec S; Royer PJ; Pain M; Combredet C; Mesel-Lemoine M; Cellerin L; Magnan A; Tangy F; Grégoire M; Fonteneau JF
Oncotarget; 2015 Dec; 6(42):44892-904. PubMed ID: 26539644
[TBL] [Abstract][Full Text] [Related]
6. Proteome profiling of virus-host interactions of wild type and attenuated measles virus strains.
Billing AM; Kessler JR; Revets D; Sausy A; Schmitz S; Barra C; Muller CP
J Proteomics; 2014 Aug; 108():325-36. PubMed ID: 24914991
[TBL] [Abstract][Full Text] [Related]
7. Engineering oncolytic measles virus to circumvent the intracellular innate immune response.
Haralambieva I; Iankov I; Hasegawa K; Harvey M; Russell SJ; Peng KW
Mol Ther; 2007 Mar; 15(3):588-97. PubMed ID: 17245355
[TBL] [Abstract][Full Text] [Related]
8. T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue.
Stubblefield Park SR; Widness M; Levine AD; Patterson CE
J Virol; 2011 Apr; 85(7):3664-76. PubMed ID: 21270150
[TBL] [Abstract][Full Text] [Related]
9. Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.
Aref S; Castleton AZ; Bailey K; Burt R; Dey A; Leongamornlert D; Mitchell RJ; Okasha D; Fielding AK
Mol Ther; 2020 Apr; 28(4):1043-1055. PubMed ID: 32087150
[TBL] [Abstract][Full Text] [Related]
10. Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549.
Helin E; Vainionpää R; Hyypiä T; Julkunen I; Matikainen S
Virology; 2001 Nov; 290(1):1-10. PubMed ID: 11882993
[TBL] [Abstract][Full Text] [Related]
11. Intracellular transport of the measles virus ribonucleoprotein complex is mediated by Rab11A-positive recycling endosomes and drives virus release from the apical membrane of polarized epithelial cells.
Nakatsu Y; Ma X; Seki F; Suzuki T; Iwasaki M; Yanagi Y; Komase K; Takeda M
J Virol; 2013 Apr; 87(8):4683-93. PubMed ID: 23408617
[TBL] [Abstract][Full Text] [Related]
12. Measles to the Rescue: A Review of Oncolytic Measles Virus.
Aref S; Bailey K; Fielding A
Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
[TBL] [Abstract][Full Text] [Related]
13. Induction of dendritic cell production of type I and type III interferons by wild-type and vaccine strains of measles virus: role of defective interfering RNAs.
Shivakoti R; Siwek M; Hauer D; Schultz KL; Griffin DE
J Virol; 2013 Jul; 87(14):7816-27. PubMed ID: 23678166
[TBL] [Abstract][Full Text] [Related]
14. Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
Kurokawa C; Iankov ID; Anderson SK; Aderca I; Leontovich AA; Maurer MJ; Oberg AL; Schroeder MA; Giannini C; Greiner SM; Becker MA; Thompson EA; Haluska P; Jentoft ME; Parney IF; Weroha SJ; Jen J; Sarkaria JN; Galanis E
J Natl Cancer Inst; 2018 Oct; 110(10):1123-1132. PubMed ID: 29788332
[TBL] [Abstract][Full Text] [Related]
15. Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus.
Shingai M; Ebihara T; Begum NA; Kato A; Honma T; Matsumoto K; Saito H; Ogura H; Matsumoto M; Seya T
J Immunol; 2007 Nov; 179(9):6123-33. PubMed ID: 17947687
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus.
Allagui F; Achard C; Panterne C; Combredet C; Labarrière N; Dréno B; Elgaaied AB; Pouliquen D; Tangy F; Fonteneau JF; Grégoire M; Boisgerault N
Curr Gene Ther; 2017; 16(6):419-428. PubMed ID: 28042780
[TBL] [Abstract][Full Text] [Related]
17. The MyD88 pathway in plasmacytoid and CD4+ dendritic cells primarily triggers type I IFN production against measles virus in a mouse infection model.
Takaki H; Takeda M; Tahara M; Shingai M; Oshiumi H; Matsumoto M; Seya T
J Immunol; 2013 Nov; 191(9):4740-7. PubMed ID: 24078691
[TBL] [Abstract][Full Text] [Related]
18. Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil function.
Zhang Y; Patel B; Dey A; Ghorani E; Rai L; Elham M; Castleton AZ; Fielding AK
J Immunol; 2012 Feb; 188(3):1002-10. PubMed ID: 22180616
[TBL] [Abstract][Full Text] [Related]
19. Hostile communication of measles virus with host innate immunity and dendritic cells.
Hahm B
Curr Top Microbiol Immunol; 2009; 330():271-87. PubMed ID: 19203114
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains.
Tanabe M; Kurita-Taniguchi M; Takeuchi K; Takeda M; Ayata M; Ogura H; Matsumoto M; Seya T
Biochem Biophys Res Commun; 2003 Nov; 311(1):39-48. PubMed ID: 14575692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
